With Flatiron Assist™ surfacing and prioritizing appropriate regimens for physicians, based on key clinical and prognostic factors, we are driving value with every treatment decision.

Flatiron was chosen because it’s fit-for-purpose. You have the right population and good sample size. Unstructured data covers the primary endpoint of the trial, which is overall response rate. A key learning is you need to choose a database that is fit-for-purpose with good quality.

Working with partners like Flatiron and technology like [Flatiron] Clinical Pipe™ and Flatiron Vessel™ has been an excellent opportunity for us to really build processes and systems around the technology that is available today and get those technologies to work together.